DeRyckere, Deborah
Huelse, Justus M. http://orcid.org/0000-0002-1541-1617
Earp, H. Shelton
Graham, Douglas K. http://orcid.org/0000-0002-6201-6900
Article History
Accepted: 7 August 2023
First Online: 4 September 2023
Competing interests
: H.S.E. and D.K.G. are founders and serve on the Scientific Advisory Board of Meryx, and D.K.G. also serves on the Board of Directors. D.D., H.S.E. and D.K.G. hold equity in Meryx. The key clinical candidate therapeutic being developed by Meryx, MRX-2843, is discussed in this Review.